News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
52,094 Results
Type
Article (3925)
Company Profile (30)
Press Release (48139)
Section
Business (15385)
Career Advice (69)
Deals (2024)
Drug Delivery (9)
Drug Development (4771)
Employer Resources (3)
FDA (822)
Job Trends (1414)
News (22797)
Policy (1770)
Tag
Academia (450)
Accelerated approval (4)
Allergies (3)
Alliances (5861)
ALS (17)
Alzheimer's disease (88)
Antibody-drug conjugate (ADC) (18)
Approvals (835)
Artificial intelligence (84)
Autoimmune disease (6)
Automation (11)
Bankruptcy (18)
Best Places to Work (1262)
BIOSECURE Act (12)
Biosimilars (2)
Biotechnology (25)
Bladder cancer (18)
Brain cancer (6)
Breast cancer (189)
Cancer (710)
Cardiovascular disease (17)
Career advice (70)
Career pathing (3)
CAR-T (25)
Celiac Disease (1)
Cell therapy (85)
Cervical cancer (1)
Clinical research (3736)
Collaboration (244)
Compensation (41)
Complete response letters (2)
COVID-19 (230)
CRISPR (42)
C-suite (65)
Cystic fibrosis (13)
Data (612)
Depression (4)
Diabetes (21)
Diagnostics (1520)
Digital health (4)
Diversity, equity & inclusion (1)
Drug discovery (25)
Drug pricing (2)
Duchenne muscular dystrophy (23)
Earnings (4339)
Editorial (1)
Employer branding (1)
Employer resources (3)
Events (7801)
Executive appointments (88)
FDA (997)
Friedreich's ataxia (1)
Funding (110)
Gene editing (97)
Generative AI (5)
Gene therapy (91)
GLP-1 (40)
Government (323)
Guidances (35)
Healthcare (1398)
HIV (2)
Huntington's disease (4)
IgA nephropathy (1)
Immunology and inflammation (7)
Immuno-oncology (6)
Indications (9)
Infectious disease (244)
Inflammatory bowel disease (11)
Influenza (7)
Intellectual property (17)
Interviews (8)
IPO (925)
Job creations (189)
Job search strategy (65)
JPM (3)
Kidney cancer (1)
Labor market (3)
Layoffs (26)
Legal (332)
Liver cancer (9)
Longevity (3)
Lung cancer (104)
Lymphoma (28)
Machine learning (8)
Management (1)
Manufacturing (48)
MASH (6)
Medical device (431)
Medtech (433)
Mergers & acquisitions (1160)
Metabolic disorders (44)
Multiple sclerosis (3)
NASH (1)
Neurodegenerative disease (28)
Neuropsychiatric disorders (3)
Neuroscience (180)
NextGen: Class of 2026 (421)
Non-profit (331)
Now hiring (4)
Obesity (15)
Opinion (35)
Ovarian cancer (8)
Pain (14)
Pancreatic cancer (26)
Parkinson's disease (32)
Partnered (1)
Patents (27)
Patient recruitment (20)
Peanut (1)
People (4848)
Pharmaceutical (3)
Pharmacy benefit managers (1)
Phase 1 (1436)
Phase 2 (1729)
Phase 3 (1261)
Pipeline (391)
Policy (18)
Postmarket research (80)
Preclinical (783)
Press Release (22)
Prostate cancer (25)
Radiopharmaceuticals (6)
Rare diseases (95)
Real estate (369)
Regulatory (1356)
Reports (3)
Research institute (537)
Resumes & cover letters (3)
Rett syndrome (6)
RSV (2)
Schizophrenia (7)
Series A (24)
Series B (16)
Sickle cell disease (25)
Spinal muscular atrophy (2)
Sponsored (3)
Startups (379)
Supply chain (6)
Tariffs (1)
Vaccines (29)
Venture capital (5)
Weight loss (6)
Date
Last 7 days (34)
Last 30 days (131)
Last 365 days (2199)
2026 (205)
2025 (2282)
2024 (3209)
2023 (3763)
2022 (4964)
2021 (5070)
2020 (4343)
2019 (3329)
2018 (2505)
2017 (2823)
2016 (2732)
2015 (2831)
2014 (1825)
2013 (1554)
2012 (1554)
2011 (1585)
2010 (1410)
Location
Africa (66)
Alabama (9)
Alaska (1)
Arizona (23)
Asia (2587)
Australia (391)
California (1177)
Canada (147)
China (73)
Colorado (50)
Connecticut (90)
Delaware (25)
Europe (6667)
Florida (118)
Georgia (6)
Hawaii (2)
Idaho (1)
Illinois (40)
India (4)
Indiana (24)
Iowa (8)
Japan (33)
Kansas (4)
Kentucky (2)
Louisiana (4)
Maine (4)
Maryland (141)
Massachusetts (707)
Michigan (15)
Minnesota (27)
Mississippi (1)
Missouri (10)
Montana (2)
Nebraska (5)
Nevada (6)
New Hampshire (3)
New Jersey (177)
New Mexico (11)
New York (175)
North Carolina (186)
North Dakota (7)
Northern California (595)
Ohio (36)
Oklahoma (1)
Oregon (3)
Pennsylvania (89)
Rhode Island (3)
South America (64)
South Carolina (3)
Southern California (430)
Tennessee (6)
Texas (208)
United States (3444)
Utah (38)
Virginia (13)
Washington D.C. (4)
Washington State (71)
Wisconsin (22)
52,094 Results for "ers genomics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
November 10, 2025
·
5 min read
Press Releases
Life Biosciences Announces FDA Clearance of IND Application for ER-100 in Optic Neuropathies
January 29, 2026
·
3 min read
Business
ERS Genomics Appoints John E Milad as Chief Executive Officer
ERS Genomics Limited, the CRISPR licensing company, announced the appointment of John E Milad as CEO, with immediate effect.
May 13, 2024
·
3 min read
Ricoh and ERS Genomics Enter into CRISPR/Cas9 License Agreement
Ricoh Company, Ltd. announced a non-exclusive licensing agreement in the USA and Japan with ERS Genomics Limited for access to the foundational CRISPR/Cas9 genome editing technology patents managed by ERS Genomics.
March 13, 2024
·
2 min read
ERS Genomics and IRBM Sign CRISPR/Cas9 License Agreement
ERS Genomics Limited, the CRISPR licensing Company, and IRBM, a leader in the field of drug discovery, announced a non-exclusive CRISPR/Cas9 license agreement.
May 20, 2024
·
2 min read
Press Releases
One Genomics and CiRA Foundation Announce Strategic Research Collaboration to Advance Precision Genome Engineering
January 9, 2026
·
2 min read
Press Releases
ERS Genomics launches ‘Express License’ platform to democratise access to CRISPR/Cas9
January 14, 2025
·
3 min read
Press Releases
Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer
December 11, 2025
·
7 min read
Press Releases
Roche’s giredestrant reduced risk of invasive disease recurrence or death by 30% in ER-positive early-stage breast cancer
December 10, 2025
·
13 min read
Press Releases
Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care
January 8, 2026
·
5 min read
1 of 5,210
Next
